Skip to content
Search

Latest Stories

Guidance released to treat minor eye ailments in Scottish pharmacies

The Scottish government has released guidance for the treatment of minor eye conditions in community pharmacies.

The latest update provides guidance to both community optometry and community pharmacy teams for the assessment and treatment of minor eye conditions under the NHS Pharmacy First Scotland (NHS PFS) service.


According to the guidance, if an optometrist concludes that a patient requires treatment for a minor eye condition, he or she could refer the patient to a pharmacy rather than their GP practice, to obtain a necessary medication.

In such cases, the optometrist can use the necessary form attached to the guidance to request that a supply is made through NHS PFS.

This ensures patients can access the most appropriate service to meet their individual needs in timely manner.

As before with the Minor Ailment Service (MAS), the optometrist’s clinical assessment would be utilised prior to a supply being made and the responsibility for the choice of product based on examination remains with the referring optometrist, the guidance has said.

“Patients who present in the first instance to a pharmacy and do not, in the pharmacist’s opinion, need to go directly to hospital should be directed to a local optometry practice for an eye examination using the same form,” the guidance has said.

“It is good practice that the referring pharmacy contacts the optometry practice by telephone, whilst the patient is still in the pharmacy to confirm availability of an appointment, thus providing a better patient experience. However, this may not always be possible,” it added.

At all times it is essential that patient has a clear understanding of their journey between optometry and pharmacy to ensure this is efficient and safe, whilst allowing the respective healthcare professionals to manage their workloads, the guidance stated.

“After the first supply, the patient should be reviewed by an optometrist to assess the need for ongoing treatment. At this point, a further supply could be made by the pharmacy (to ensure continuity of treatment) and a request submitted by the optometrist to the GP to add the item to the patient’s repeat prescription. The route of obtaining further supplies should be made clear to the patient at this point,” the guidance has said.

More For You

Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less